نتایج جستجو برای: iscoms

تعداد نتایج: 95  

Journal: :The Journal of Experimental Medicine 1992
R S van Binnendijk C A van Baalen M C Poelen P de Vries J Boes V Cerundolo A D Osterhaus F G UytdeHaag

The routes used by antigen-presenting cells (APC) to convert the transmembrane fusion glycoprotein (F) of measles virus (MV) to HLA class I and class II presentable peptides have been examined, using cloned cytotoxic T lymphocytes in functional assays. Presentation by Epstein-Barr virus-transformed B lymphoblastoid cell lines was achieved using live virus, ultraviolet light-inactivated virus, a...

Journal: :Journal of virology 1990
M T Bejarano M G Masucci A Morgan B Morein G Klein E Klein

The ability of B cells, B blasts, and macrophages to present Epstein-Barr virion antigens to autologous T cells and trigger their capacity to inhibit Epstein-Barr virus-induced B-cell transformation was tested. Macrophages were as efficient as B cells and B blasts in presenting the virus to T lymphocytes. This function required antigen processing, because it was inhibited by chloroquine treatme...

Journal: :Vaccine 1992
M Fekadu J H Shaddock J Ekström A Osterhaus D W Sanderlin B Sundquist B Morein

Dogs and mice were immunized with either a rabies glycoprotein subunit vaccine incorporated into an immune stimulating complex (ISCOM) or a commercial human diploid cell vaccine (HDCV) prepared from a Pitman Moore (PM) rabies vaccine strain. Pre-exposure vaccination of mice with two intraperitoneal (i.p.) doses of 360 ng ISCOM or 0.5 ml HDCV protected 95% (38/40) and 90% (36/40) of mice, respec...

2012
Juanjuan Chen Lijie Zhang Weigang Wen Jiaqing Hao Pumei Zeng Xiaoping Qian Yu Zhang Yanhui Yin

HCA587 (also known as MAGE-C2) is a "cancer-testis" antigen highly expressed in a number of malignancies with unique immunological properties, making it a promising target for tumor immunotherapy. In this report, we demonstrated that HCA587 protein, when formulated with adjuvants CpG-containing oligodeoxynucleotides (CpG ODN) and ISCOM, was capable of inducing a potent cellular and humoral immu...

Journal: :Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2007
Takami Akagi Masanori Baba Mitsuru Akashi

The development of a prophylactic/therapeutic HIV-1 vaccine based on recombinant proteins is needed for the control of the worldwide AIDS epidemic. Subunit protein and peptide vaccines are generally very safe, with well-defined components. However, these antigens are often poorly immunogenic, and thus require the use of adjuvants to induce adequate immunity. Particulate adjuvants (e.g. micro/na...

Journal: :Clinical and vaccine immunology : CVI 2014
Sara Hägglund Kefei Hu Krister Blodörn Boby Makabi-Panzu Anne-Laure Gaillard Karin Ellencrona Didier Chevret Lars Hellman Karin Lövgren Bengtsson Sabine Riffault Geraldine Taylor Jean François Valarcher Jean-François Eléouët

Bovine respiratory syncytial virus (BRSV) and human respiratory syncytial virus (HRSV) are major causes of respiratory disease in calves and children, respectively, and are priorities for vaccine development. We previously demonstrated that an experimental vaccine, BRSV-immunostimulating complex (ISCOM), is effective in calves with maternal antibodies. The present study focuses on the antigenic...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید